The biological evaluation of the novel compounds showed that (±)-1 and (±)-2 displayed notable inhibitory effects on the expression of fibronectin, collagen I, and α-SMA in TGF-β1-induced NRK-52E cells, indicating their potential usage in the treating of renal fibrosis. This evidence concerns the gene ACTA1 and renal fibrosis.